Liz Gold

Associate
lgold@cooley.com
Full contact info

About Liz

Liz Gold advises emerging and high growth companies through all stages of the corporate lifecycle, from formation to day to day corporate governance, venture financings, mergers and acquisitions and public offerings. Liz also provides counsel to venture capital investors in financing transactions.

View full bio

Experience

Enavate Sciences Co-Leads Normunity’s $75 Million Series B

Enavate Sciences Co-Leads Normunity’s $75 Million Series B

January 13, 2025

Cooley advised Enavate Sciences, a top investment firm, as the co-lead investor in the $75 million Series B financing round of Normunity, a biotechnology company creating novel anticancer therapies. Lawyers Marc Recht, Brandon Fenn and Barry Kuang led the Cooley team advising Enavate Sciences.

Related contacts

Marc Recht
Partner, Boston
Brandon W. Fenn
Partner, New York
Barry Kuang
Associate, Boston
Liz Gold
Associate, New York
Stephanie Gentile
Partner, New York

Related Practices & Industries

Emerging Companies
Venture Capital
Life Sciences
Tax

DigitalOcean Acquires Paperspace for $111 Million

DigitalOcean Acquires Paperspace for $111 Million

July 6, 2023

Cooley advised DigitalOcean, a cloud computing solution for small and medium-sized businesses and startups, on its acquisition of Paperspace for $111 million.

Read more

Related contacts

Bill Roegge
Partner, New York
Adam Dinow
Partner, New York
Brad Goldberg
Partner, New York
Kevin Cooper
Partner, New York
Stephanie Gentile
Partner, New York
Ellie Seber
Partner, Santa Monica
Len Jacoby
Partner, New York
Barbara Mirza
Partner, Santa Monica
Howard Morse
Senior Counsel, Washington, DC
Ryan Vann
Partner, Chicago
Sharon Connaughton
Special Counsel, Washington, DC
Annie Froehlich
Partner, Washington, DC
Karun Ahuja
Special Counsel, Chicago
Cara Buchicchio
Associate, New York
Liz Gold
Associate, New York
Austin Holt
Partner, Santa Monica
Kristin R. Marshall
Associate, Washington, DC
Anisha Mohin
Associate, New York
Patrick Sharma
Associate, Santa Monica
Rubin Waranch
Associate, Colorado

Related Practices & Industries

Mergers and Acquisitions
Artificial Intelligence
Technology
Technology Transactions
Emerging Companies
Public Company Advisory Team
Compensation and Benefits
Labor and Employment
Debt Finance
Tax
Antitrust and Competition
Cyber/Data/Privacy

Oyster Point Pharma to Be Acquired by Viatris

Oyster Point Pharma to Be Acquired by Viatris

November 10, 2022

Cooley advised Oyster Point Pharma, a top ophthalmology-focused biopharmaceutical company, on its definitive agreement to be acquired by global healthcare company Viatris. Partners Mika Reiner Mayer, Brandon Fenn, Div Gupta and Ian Nussbaum led the Cooley team advising Oyster Point Pharma.

Read more

Related contacts

Mika Reiner Mayer
Partner, Palo Alto
Brandon W. Fenn
Partner, New York
Div Gupta
Partner, New York
Sarah Lightdale
Partner, New York
Eileen Marshall
Partner, Washington, DC
Howard Morse
Senior Counsel, Washington, DC
John Paul Oleksiuk
Partner, New York
Nyron J. Persaud
Partner, New York
Charity Williams
Partner, San Diego
Natasha Leskovsek
Of Counsel, Washington, DC
Ryan Montgomery
Partner, Boston
Thomas Welk
Senior Counsel, San Diego
Nathan Baum
Special Counsel, New York
Kimberly Bolin
Patent Agent, Palo Alto
Julia R. Brinton
Special Counsel, Washington, DC
Cara Buchicchio
Associate, New York
Colette Ghazarian
Associate, Los Angeles
Liz Gold
Associate, New York
Edward (Teddy) Nimetz
Associate, New York

Related Practices & Industries

Mergers and Acquisitions
Life Sciences
Capital Markets
Public Companies

Admissions and credentials

New York